Michael P. Kelly, President, Global Markets at HAEMONETICS CORP (HAE), sold 1,400 shares at $40.41 ($57K) on 2013-10-14, disclosed to the SEC on 2013-10-15.
Scheduled sale ($57k) by President, Global Markets under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| FALC | BUY | 2014-12-16 | $26K | — | Filing → |
| HAE | SELL | 2013-11-13 | $2.4M | — | Filing → |
| HAE | SELL | 2013-09-17 | $57K | — | Filing → |